z-logo
Premium
Analysing pharmacokinetic drug interaction or comparability studies with missing values in crossover design
Author(s) -
Wei Lynn,
Zhang Ji,
Larson Patrick
Publication year - 2003
Publication title -
pharmaceutical statistics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.421
H-Index - 38
eISSN - 1539-1612
pISSN - 1539-1604
DOI - 10.1002/pst.13
Subject(s) - comparability , crossover study , crossover , pharmacokinetics , missing data , statistics , drug , bioequivalence , econometrics , mathematics , pharmacology , computer science , medicine , artificial intelligence , alternative medicine , pathology , combinatorics , placebo
In a pharmacokinetic drug interaction study using a three‐period, three‐treatment (drug A, drug B, and drugs A and B concomitantly) crossover design, pharmacokinetic parameters for either drug are only measured in two of the three periods. Similar missing data problems can arise for a four‐period, four‐treatment crossover pharmacokinetic comparability study. This paper investigates whether the usual ANOVA model for the crossover design can be applied under this pattern of missing data. It is shown that the model can still be used, contrary to a belief that a new one is needed. The effect of this type of missing data pattern on the statistical properties of treatment, period and carryover effect estimates was derived and illustrated by means of simulations and an example. Copyright © 2003 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here